Literature DB >> 1000023

Bilirubin and paranitrophenol glucuronyl transferase activities and ultrastructural aspect of the liver in patients with chronic hemolytic anemias.

C Auclair, G Feldmann, J Hakim, P Boivin, J Boucherot.   

Abstract

The hepatic ultrastructural aspect and the hepatic bilirubin (Bil-GT) and paranitrophenol (PNP-GT) glucuronyl transferase activities were studied in twenty subjects with a chronic hemolytic anemia (HA) and five subjects with an aplastic anemia. In chronic HA: the hepatic ultrastructural aspect showed mitochondrial abnormalities affecting structure (paracrystalline inclusions), size (giant mitochondria) and shape (irregular mitochondria); there was a decrease of Bil-GT activity in 80 percent of the patients. No connection could be shown between the HA etiology and the degree of the enzymatic activity decrease. The physiopathological mechanism of this enzymatic activity decrease is unknown; no deficiency of PNP-GT was observed; in chronic aplastic anemias there does not seem to be any modification, either of Bil-GT activity, or of hepatic PNP-GT activity. It is concluded that Bil-GT is often decreased in HA and that neither Bil-GT measurement nor the ultrastructural aspect of the liver distinguish chronic HA from Gilbert's syndrome.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000023

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  3 in total

Review 1.  Twenty-five years of progress in bilirubin metabolism (1952-77).

Authors:  B H Billing
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  Role of bilirubin overproduction in revealing Gilbert's syndrome: is dyserythropoiesis an important factor?

Authors:  J M Metreau; J Yvart; D Dhumeaux; P Berthelot
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

3.  Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease.

Authors:  J Fevery; N Blanckaert; K P Heirwegh; A M Préaux; P Berthelot
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.